Stock listing

HKEX:6887 Sunshine Lake Pharma Co., Ltd. (東陽光藥) 股價

Follow Sunshine Lake Pharma Co., Ltd. into a list and get an email when it puts out news.

Share price · HKEX:6887

$39.40 HKD -0.20 (-0.5%)

Close on Oct 14, 2026

Sunshine Lake Pharma Co., Ltd. logo
Ticker
HKEX:6887
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
HKEX
Currency
HKD

What changed lately

Latest news

Voluntary announcement Insulin Degludec and Insulin Aspart Injection obtained marketing approval from the china national medical products administration

Oct 8, 2026

Next Day Disclosure Return

Oct 2, 2026

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026

Oct 2, 2026

Interim Report 2026

Sep 30, 2026

Inside information filing with the CSRC in relation to the proposed implementation of h share full circulation

Sep 23, 2026

Lannett Company, Lanexa Biologics and Sunshine Lake Pharma announce FDA Approval of LANGLARA™ an Interchangeable Biosimilar of Lantus® (insulin glargine)

May 4, 2026

Sunshine Lake Pharma Co., Ltd. (06887.HK) Completes Listing, Market Capitalisation Expected to Rapidly Surpass RMB 50 Billion

Aug 5, 2025

All Sunshine Lake Pharma Co., Ltd. news

Sunshine Lake Pharma Co., Ltd. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
8 in the last 12 months · 9 in all · newest Oct 8, 2026 · oldest 2025

Log in to ask 6ix AI your own questions about Sunshine Lake Pharma Co., Ltd.